Helius medical technologies.
Exhibit 3.1 . CERTIFICATE OF AMENDMENT. TO THE. CERTIFICATE OF INCORPORATION. OF. HELIUS MEDICAL TECHNOLOGIES, INC. Helius Medical Technologies, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), does …
Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with …NEWTOWN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on …Jul 12, 2022 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... Helius Medical Technologies, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), certifies that: 1. The Certificate of Amendment to the Certificate of Incorporation that was filed with the Delaware Secretary of State on August 15, 2023 requires correction as permitted by Section 103(f) of ...About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people ...
As of September 30, 2023, we had $6.6 million in cash and no debt and $4 million in proceeds receivable from warrant exercises as of September 30, 2023, and we expect our cash runway to extend ...Nov 13, 2023 · Welcome to the Third Quarter 2023 Earnings Conference Call for Helius Medical Technologies. This is Michelle Bilski of In-Site Communications, Investor Relations for Helius. With me on today’s ...
Helius Medical Technologies has extended by six months a program that allows multiple sclerosis (MS) patients in the U.S. to access its Portable Neuromodulation Stimulator (PoNS) device at a ...About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people ...
Nov 17, 2022 · Earnings Estimate Revisions for Helius Medical Technologies, Inc. For the fiscal year ending December 2022, this company is expected to earn -$1.75 per share, which is a change of 76.3% from the ... Helius Medical Technologies, Inc. Class A Common Stock (DE) (HSDT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s...
Helius Medical Technologies, Inc. HSDT shares are trading higher on Tuesday after the company gained compliance with all applicable Nasdaq listing criteria. The Details: Helius Medical ...
NEWTOWN, Pa., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on …
Helius Medical Technologies. The Newtown medical technology company published study results demonstrating its portable neuromodulation stimulator, or PoNS, can “drastically” improve return-to ...Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Earnings for Helius Medical Technologies are expected to grow in the coming year, from ($8.73) to ($6.26) per share. Helius Medical Technologies has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 14th, 2024 based off prior year's report dates. Read More.About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Helius Medical Technologies, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.11. Operator: Good day, and thank you for standing by.
May 11, 2023 · About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic ... Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024. Globe Newswire - Nov 2, 2023, 5:05PM.NEWTOWN, Pa., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on …Earnings Estimate Revisions for Helius Medical Technologies, Inc. For the fiscal year ending December 2022, this company is expected to earn -$1.75 per share, which is a change of 76.3% from the ...Aug 7, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...
Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that ...Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q3 2023 Earnings Call Transcript November 12, 2023 Operator: Good day, everyone. My name is Chelsea, and I will be your conference operator.
Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people ...Aug 7, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brainâ s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. Helius Medical Technologies, PoNS Device, UpScript. Recent Posts. Smoking during pregnancy tied to raised MS risk in mothers, offspring; Hackensack Meridian’s status as comprehensive care center ...Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform ...The Investor Relations website contains information about Helius Medical Technologies, Inc.'s business for stockholders, potential investors, and financial analysts.Dec 1, 2023 · Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024. GlobeNewswire Nov 2, 2023 9:05pm. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...Number of Employee Profiles 2. Helius Medical Technologies has 2 current employee profiles, including Founder Montel Williams. Montel Williams Founder. Jonathan Mark Sackier Chief Medical Officer.
Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...
The Portable Neuromodulation Stimulator (PoNS®) is an innovative technology in treating gait and balance deficit in individuals with neurological disorders, to improve function. The PoNS device is an innovative technology to help individuals with chronic neurological symptoms of disease or trauma. It includes a controller and mouthpiece that ...
Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using an orally applied technology platform that amplifies the brain’s ...About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...Sep 21, 2023 · About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. Welcome to the fourth quarter and year-end 2022 Earnings Conference Call for Helius Medical Technologies. This is Michelle Bilski of Insight Communications, Investor Relations for Helius. With me ...About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases.Helius Medical Technologies, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.11. Operator: Good day, and thank you for standing by.About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic ...On February 16, 2020, Mr. Thomas Griffin notified the Board of Directors (the “Board”) of Helius Medical Technologies, Inc. (the “Company”) of his intent not to run for reelection at the Company’s 2020 annual meeting of stockholders (the “Annual Meeting”). His term as director of the Company will conclude at the Annual Meeting. Mr.
Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ...Instagram:https://instagram. fun cities in usfull coverage dental insurance azsnowflakes stock price todayfinancial advisor knoxville Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Helius Medical Technologies, Inc.’s Post Helius Medical Technologies, Inc. 2,527 followers 3d Report this post Looking to stay informed about the latest news on Helius Medical and PoNS Therapy spyv holdingsdrv holdings Nov 30, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ... ocnb NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced that its President and Chief Executive Officer, Dane Andreeff, will be presenting at the NobleCon 19th Annual Emerging Growth Equity Conference. The event is set to take place on Tuesday, December 5, 2023, at 2:00 pm ET in Boca Raton, Florida.Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company’s product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short …Helius Medical Technologies, Inc.’s Post Helius Medical Technologies, Inc. 2,527 followers 3d Report this post Looking to stay informed about the latest news on Helius Medical and PoNS Therapy